2019

Cancer Killers

Fusion Raises $105m in Series B Financing.

Fusion, Latest News /

Hamilton, Ontario and Dublin, Ireland.  April 2nd 2019.  Seroba’s portfolio company, Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer, today announced the completion of a $105 million Series B financing led by Varian and new investor OrbiMed Advisors. Seroba participated in the round alongside new investors including Perceptive Advisors, Pivotal […]

Fusion Raises $105m in Series B Financing. Read More »

Fusion Round

First Patient Dosed in Fusion Phase I trial.

Fusion, Latest News /

Boston, Massachusetts & Hamilton, Ontario.  February 19, 2019.  Seroba portfolio company, Fusion Pharmaceuticals, a biopharmaceutical company focused on radiotherapeutics (targeted alpha therapeutics) has announced the first patient was dosed in a Phase 1, first-in-human clinical trial of lead product candidate [225Ac]-FPI-1434 in patients with advanced solid tumors. “The entire Fusion team takes tremendous pride in

First Patient Dosed in Fusion Phase I trial. Read More »

Labcyte Round

Labcyte Sold to Beckman Coulter.

Labcyte, Latest News /

Dublin, Ireland.  30 January 2019.  Seroba portfolio company, Labcyte, has been acquired by Beckman Coulter Life Sciences, part of the larger Danaher Corporation which generates approximately $6.5 billion in annual revenue. Labcyte is best known for its Echo® acoustic droplet ejection technology, which uses sound waves to transfer tiny amounts of liquid with unequalled speed

Labcyte Sold to Beckman Coulter. Read More »

Atlantic Innove

Atlantic Therapeutics Raise €28M in Series B Funding.

Atlantic, Latest News /

Galway, Ireland.  7 January 2019.  Atlantic Therapeutics, the medical technology company developing garment-based pelvic floor muscle strengthening and nerve stimulation devices treating the cause of bladder leaks, has announced that it has closed €28 million in Series B funding to continue its rapid growth trajectory. Having recently gained FDA clearance for its INNOVO® therapy device,

Atlantic Therapeutics Raise €28M in Series B Funding. Read More »

Quanta Sc

Quanta Appoints New Chief Medical Officer

Latest News, Quanta /

Alcester, UK, 4 Jan 2019: Seroba portfolio company, Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical device company providing innovative haemodialysis solutions for clinic and home settings, today announced the Company has appointed Dr Paul Komenda as CMO. Quanta has also announced that it will be at the JP Morgan Healthcare Conference in

Quanta Appoints New Chief Medical Officer Read More »

We use cookies and analytics to improve your online experience and to help us to understand where our audience is and how they reach us, as well as to understand what topics and site features are of greatest interest.  To find out more, please read our Privacy Policy. By clicking on the Accept button, you consent to our use of cookies and browsing analytics.

Scroll to Top